Through use of a monoclonal antibody against CacyBP/SIP [10], we have shown that overexpression of CacyBP/SIP inhibits the proliferation and tumorgenesis of renal cancer cells [11]. The gene discussed is CACYBP; the disease is renal carcinoma.